首页 > 最新文献

Endocrine, metabolic & immune disorders drug targets最新文献

英文 中文
A Comprehensive Overview of Hibiscus rosa-sinensis L.: Its Ethnobotanical Uses, Phytochemistry, Therapeutic Uses, Pharmacological Activities, and Toxicology. 芙蓉的全面概述:民族植物学用途、植物化学、治疗用途、药理活性和毒理学。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230522113405
Smail Amtaghri, Adil Qabouche, Miloudia Slaoui, Mohamed Eddouks

Hibiscus rosa-sinensis (H. rosa-sinensis) has been largely used in traditional medicine. This study aims to review the pharmacological and phytochemical properties of Hibiscus rosa-sinensis L and also summarize the pharmacological, photochemical, and toxicological characteristics of H. rosa-sinensis. The current review focuses on the distribution, chemical content, and main uses of H. rosa-sinensis. Various scientific databases, including ScienceDirect, Scopus, PubMed, Google Scholar, etc., were used. Correct plant names were verified from plantlist.org. The results were interpreted, analyzed, and documented based on bibliographic information. This plant has been frequently used in conventional medicine due to its high concentration of phytochemicals. All its parts contain numerous chemical compounds, such as flavonoids, tannins, terpenoids, anthocyanins, saponins, cyclopeptide alkaloids, and vitamins. More interestingly, the roots of this plant contain glycosides, tannins, phytosterols, fixed oils, fats, flavonoids, saponins, gums, and mucilages. The leaves contain alkaloids, glycosides, reducing sugars, fat, resin, and sterols. The stem contains other chemical compounds, such as ß-sitosterol, teraxeryl acetate, cyclic sterculic, and malvalic acids. Finally, the flowers contain riboflavin, thiamine, apigenidine, oxalic acid, citric acid, quercetin, niacin, pelargonidine, and ascorbic acid. This species has a wide variety of pharmacological applications, such as antimicrobial, antioxidant, antidiabetic, anti-inflammatory, antihypertensive, antifertility, antifungal, anticancer, hair growth-promoting, antihyperlipidemic, reproductive, neurobehavioral, antidepressant, and antipyretic activities. Finally, toxicological studies have shown that higher doses of extracts from the plant are safe.

木槿(Hibiscus rosa-sinensis)在传统医学中被广泛使用。本研究旨在综述木槿的药理和植物化学特性,并总结木槿的药理、光化学和毒理学特征。本综述重点介绍了木芙蓉的分布、化学成分和主要用途。使用了各种科学数据库,包括 ScienceDirect、Scopus、PubMed、Google Scholar 等。植物名称的正确性通过 plantlist.org 进行了验证。根据文献信息对结果进行了解释、分析和记录。这种植物因其富含植物化学物质而经常被用于传统医学。它的所有部分都含有大量化合物,如类黄酮、单宁、萜类化合物、花青素、皂甙、环肽生物碱和维生素。更有趣的是,这种植物的根含有苷、单宁、植物甾醇、固定油、脂肪、类黄酮、皂甙、胶和粘液。叶片含有生物碱、苷、还原糖、脂肪、树脂和甾醇。茎中还含有其他化合物,如 ß-谷甾醇、乙酸 teraxeryl、环甾醇酸和丙戊酸。最后,花含有核黄素、硫胺素、芹菜苷、草酸、柠檬酸、槲皮素、烟酸、佩拉贡苷和抗坏血酸。该物种具有广泛的药理作用,如抗菌、抗氧化、抗糖尿病、抗炎、抗高血压、抗生育、抗真菌、抗癌、促进毛发生长、抗高脂血症、生殖、神经行为、抗抑郁和解热等活性。最后,毒理学研究表明,较高剂量的植物提取物是安全的。
{"title":"A Comprehensive Overview of <i>Hibiscus rosa-sinensis</i> L.: Its Ethnobotanical Uses, Phytochemistry, Therapeutic Uses, Pharmacological Activities, and Toxicology.","authors":"Smail Amtaghri, Adil Qabouche, Miloudia Slaoui, Mohamed Eddouks","doi":"10.2174/1871530323666230522113405","DOIUrl":"10.2174/1871530323666230522113405","url":null,"abstract":"<p><p><i>Hibiscus rosa-sinensis (H. rosa-sinensis)</i> has been largely used in traditional medicine. This study aims to review the pharmacological and phytochemical properties of <i>Hibiscus rosa-sinensis</i> L and also summarize the pharmacological, photochemical, and toxicological characteristics of <i>H. rosa-sinensis</i>. The current review focuses on the distribution, chemical content, and main uses of <i>H. rosa-sinensis</i>. Various scientific databases, including ScienceDirect, Scopus, PubMed, Google Scholar, etc., were used. Correct plant names were verified from plantlist.org. The results were interpreted, analyzed, and documented based on bibliographic information. This plant has been frequently used in conventional medicine due to its high concentration of phytochemicals. All its parts contain numerous chemical compounds, such as flavonoids, tannins, terpenoids, anthocyanins, saponins, cyclopeptide alkaloids, and vitamins. More interestingly, the roots of this plant contain glycosides, tannins, phytosterols, fixed oils, fats, flavonoids, saponins, gums, and mucilages. The leaves contain alkaloids, glycosides, reducing sugars, fat, resin, and sterols. The stem contains other chemical compounds, such as ß-sitosterol, teraxeryl acetate, cyclic sterculic, and malvalic acids. Finally, the flowers contain riboflavin, thiamine, apigenidine, oxalic acid, citric acid, quercetin, niacin, pelargonidine, and ascorbic acid. This species has a wide variety of pharmacological applications, such as antimicrobial, antioxidant, antidiabetic, anti-inflammatory, antihypertensive, antifertility, antifungal, anticancer, hair growth-promoting, antihyperlipidemic, reproductive, neurobehavioral, antidepressant, and antipyretic activities. Finally, toxicological studies have shown that higher doses of extracts from the plant are safe.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"86-115"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9505770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenchymal Stem Cells and Curcumin Effectively Mitigate Freund's Adjuvant- induced Arthritis via their Anti-inflammatory and Gene Expression of COX-1, IL-6 and IL-4. 间充质干细胞和姜黄素通过抗炎及 COX-1、IL-6 和 IL-4 的基因表达有效缓解弗氏佐剂诱导的关节炎
IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230223143011
Rania Hamed Ahmed, Rasha Rashad Ahmed, Sanaa Rida Galaly, Nadia Moustafa, Mohammed Abdelwahab Sayed Abourehab, Mohamed Abdelwahab Abdelgawad, Osama Mohamed Ahmed, Manal Abdul-Hamid

Background and objectives: Rheumatoid arthritis (RA) is a type of arthritis that damages joints and can affect the thymus and the spleen. RA is an autoimmune disorder in which the immune system targets the body's own tissues. The causes of RA are unknown, although a genetic link is thought to be involved. The objective of this research was to evaluate the effect of curcumin, mesenchymal stem cells (MSCs), and their combination on the disruption of serum cytokines, ankle joint, thymus and spleen histopathology, and affected genes in complete Freund's adjuvant (CFA)-induced arthritis in male and female Wistar rats.

Methods: Experimental animals were organized into 16 groups (6 animals for each), eight groups including male rats and the other eight groups including females rats. The groups are normal control, CMC, curcumin, MSCs, CFA, CFA/curcumin, CFA/ MSCs and the arthritic group treated with MSCs and curcumin. One subcutaneous injection of 0.1 mL CFA was given to rats into the right hind leg footpad to induce RA. The arthritic rats were intravenously injected three times with bone marrow-derived MSCs (BM-MSCs) and/or treated orally with curcumin daily (100 mg per kg body weight per day) for 21 days.

Results: Curcumin and BM-MSCs work together to dramatically (P < 0.05) restore the high serum PGE2 and IL-17 levels and lower the IL-13 level in arthritic rats to normal levels. Deleterious effects on the spleen and thymus histological structure were counteracted. Gene expression of COX-1 and IL-6 was increased and IL-4 was decreased; these changes were improved by the combination treatment (P < 0.05).

Conclusion: Based on these findings, additive therapeutic effects on RA occur from the combined treatment of curcumin and BM-MSCs compared with their individual use (P < 0.05). Thus, it can be said that both curcumin and BM-MSCs are effective at reducing inflammation while also having beneficial effects on the ankle joint, thymus and spleen.

背景和目的:类风湿性关节炎(RA)是一种损害关节的关节炎,可影响胸腺和脾脏。RA 是一种自身免疫性疾病,免疫系统会攻击人体自身组织。虽然认为 RA 与遗传有关,但其病因尚不清楚。本研究旨在评估姜黄素、间充质干细胞(MSCs)及其组合对完全弗氏佐剂(CFA)诱导的雌雄 Wistar 大鼠血清细胞因子、踝关节、胸腺和脾脏组织病理学以及受影响基因的影响:将实验动物分为 16 组(每组 6 只),其中 8 组为雄性大鼠,另外 8 组为雌性大鼠。分别为正常对照组、CMC组、姜黄素组、间充质干细胞组、CFA组、CFA/姜黄素组、CFA/间充质干细胞组以及间充质干细胞和姜黄素治疗关节炎组。向大鼠右后腿足垫皮下注射 0.1 mL CFA,诱发 RA。给关节炎大鼠静脉注射三次骨髓间充质干细胞(BM-MSCs)和/或每天口服姜黄素(每公斤体重每天100毫克),共21天:结果:姜黄素和骨髓间充质干细胞共同作用,可显著(P < 0.05)恢复关节炎大鼠血清中较高的 PGE2 和 IL-17 水平,并将 IL-13 水平降至正常水平。对脾脏和胸腺组织学结构的有害影响也被抵消了。COX-1和IL-6的基因表达增加,IL-4的基因表达减少;这些变化在联合治疗后得到改善(P< 0.05):结论:根据上述研究结果,姜黄素和 BM-MSCs 联合治疗对 RA 的治疗效果优于单独使用(P< 0.05)。因此,可以说姜黄素和骨髓间充质干细胞都能有效减轻炎症,同时对踝关节、胸腺和脾脏也有益处。
{"title":"Mesenchymal Stem Cells and Curcumin Effectively Mitigate Freund's Adjuvant- induced Arthritis <i>via</i> their Anti-inflammatory and Gene Expression of COX-1, IL-6 and IL-4.","authors":"Rania Hamed Ahmed, Rasha Rashad Ahmed, Sanaa Rida Galaly, Nadia Moustafa, Mohammed Abdelwahab Sayed Abourehab, Mohamed Abdelwahab Abdelgawad, Osama Mohamed Ahmed, Manal Abdul-Hamid","doi":"10.2174/1871530323666230223143011","DOIUrl":"10.2174/1871530323666230223143011","url":null,"abstract":"<p><strong>Background and objectives: </strong>Rheumatoid arthritis (RA) is a type of arthritis that damages joints and can affect the thymus and the spleen. RA is an autoimmune disorder in which the immune system targets the body's own tissues. The causes of RA are unknown, although a genetic link is thought to be involved. The objective of this research was to evaluate the effect of curcumin, mesenchymal stem cells (MSCs), and their combination on the disruption of serum cytokines, ankle joint, thymus and spleen histopathology, and affected genes in complete Freund's adjuvant (CFA)-induced arthritis in male and female Wistar rats.</p><p><strong>Methods: </strong>Experimental animals were organized into 16 groups (6 animals for each), eight groups including male rats and the other eight groups including females rats. The groups are normal control, CMC, curcumin, MSCs, CFA, CFA/curcumin, CFA/ MSCs and the arthritic group treated with MSCs and curcumin. One subcutaneous injection of 0.1 mL CFA was given to rats into the right hind leg footpad to induce RA. The arthritic rats were intravenously injected three times with bone marrow-derived MSCs (BM-MSCs) and/or treated orally with curcumin daily (100 mg per kg body weight per day) for 21 days.</p><p><strong>Results: </strong>Curcumin and BM-MSCs work together to dramatically (P < 0.05) restore the high serum PGE2 and IL-17 levels and lower the IL-13 level in arthritic rats to normal levels. Deleterious effects on the spleen and thymus histological structure were counteracted. Gene expression of COX-1 and IL-6 was increased and IL-4 was decreased; these changes were improved by the combination treatment (P < 0.05).</p><p><strong>Conclusion: </strong>Based on these findings, additive therapeutic effects on RA occur from the combined treatment of curcumin and BM-MSCs compared with their individual use (P < 0.05). Thus, it can be said that both curcumin and BM-MSCs are effective at reducing inflammation while also having beneficial effects on the ankle joint, thymus and spleen.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"468-488"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10775225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation on Anti-diabetic Efficacy of a Cucurbitaceae Food Plant from the North-East Region of India: Exploring the Molecular Mechanism through Modulation of Oxidative Stress and Glycosylated Hemoglobin (HbA1c). 一种产自印度东北地区的葫芦科食用植物抗糖尿病功效的研究:通过调节氧化应激和糖化血红蛋白(HbA1c)探讨其分子机制。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230907115818
Sandipan Jana, Srijon Gayen, Barun Das Gupta, Seha Singha, Jayashree Mondal, Amit Kar, Abhimanyu Nepal, Suparna Ghosh, Rajan Rajabalaya, Sheba R David, Ashok Kumar Balaraman, Asis Bala, Pulok Kumar Mukherjee, Pallab Kanti Haldar

Background: The medicinal plants of the Cucurbitaceae family, such as Solena heterophylla Lour. fruits, have significant ethnobotanical value and are readily accessible in North East India.

Aims: We conducted a study on Solena heterophylla Lour. fruits to evaluate their anti-diabetic activity in vivo, standardize their HPTLC, and profile their metabolites using LC-QTOF-MS. We aimed to explore the molecular mechanism behind their effects on oxidative stress and glycosylated hemoglobin (HbA1c).

Methods: Firstly, the ethyl acetate fraction of Solena heterophylla Lour. fruits was standardized using Cucurbitacin B as a standard marker by conducting HPTLC evaluation. Next, we delved into analyzing metabolite profiling. In addition, the standardized fraction was utilized in an experimental study to investigate the molecular mechanism of action in an in vivo high-fat diet and a low dose of streptozotocin-induced diabetic model.

Results: We have reportedly identified 52 metabolites in the ethyl acetate fraction of Solena heterophylla (EASH). In the in vitro tests, it has been observed that this extract from plants possesses notable inhibitory properties against α-amylase and α-glucosidase. Solena heterophylla fruits with high levels of Cucurbitacin B (2.29% w/w) helped lower FBG levels in animals with EASH treatment. EASH treatment reduced HbA1c levels and normalized liver lipid peroxidation and antioxidant enzyme levels. SGOT, SGPT, and SALP serum enzyme levels also returned to normal.

Conclusion: Based on the current evaluation, it was found that EASH exhibited encouraging hypoglycemic effects in diabetic rats induced by a low dose of STZ and high-fat diet, which warrants further investigation.

背景:葫芦科的药用植物,如紫苏。果实,具有重要的民族植物学价值,在印度东北部很容易获得。目的:我们对大叶Solena heterophylla Lour进行了研究。以评估其体内抗糖尿病活性,标准化其HPTLC,并使用LC-QTOF-MS分析其代谢产物。目的探讨其对氧化应激和糖化血红蛋白(HbA1c)影响的分子机制。通过进行HPTLC评价,使用葫芦素B作为标准标记对水果进行标准化。接下来,我们深入分析代谢物图谱。此外,在一项实验研究中使用了标准化组分,以研究体内高脂肪饮食和低剂量链脲佐菌素诱导的糖尿病模型中的分子作用机制。结果:据报道,我们在异叶Solena(EASH)的乙酸乙酯部分中鉴定了52种代谢产物。在体外试验中,观察到这种植物提取物对α-淀粉酶和α-葡萄糖苷酶具有显著的抑制特性。具有高水平葫芦素B(2.29%w/w)的Solena heterophylla果实有助于降低EASH治疗动物的FBG水平。EASH治疗降低了HbA1c水平,使肝脏脂质过氧化和抗氧化酶水平正常化。SGOT、SGPT和SALP血清酶水平也恢复正常。结论:根据目前的评估,EASH在低剂量STZ和高脂饮食诱导的糖尿病大鼠中表现出令人鼓舞的降血糖作用,值得进一步研究。
{"title":"Investigation on Anti-diabetic Efficacy of a Cucurbitaceae Food Plant from the North-East Region of India: Exploring the Molecular Mechanism through Modulation of Oxidative Stress and Glycosylated Hemoglobin (HbA1c).","authors":"Sandipan Jana, Srijon Gayen, Barun Das Gupta, Seha Singha, Jayashree Mondal, Amit Kar, Abhimanyu Nepal, Suparna Ghosh, Rajan Rajabalaya, Sheba R David, Ashok Kumar Balaraman, Asis Bala, Pulok Kumar Mukherjee, Pallab Kanti Haldar","doi":"10.2174/1871530323666230907115818","DOIUrl":"10.2174/1871530323666230907115818","url":null,"abstract":"<p><strong>Background: </strong>The medicinal plants of the Cucurbitaceae family, such as <i>Solena heterophylla</i> Lour. fruits, have significant ethnobotanical value and are readily accessible in North East India.</p><p><strong>Aims: </strong>We conducted a study on <i>Solena heterophylla</i> Lour. fruits to evaluate their anti-diabetic activity in vivo, standardize their HPTLC, and profile their metabolites using LC-QTOF-MS. We aimed to explore the molecular mechanism behind their effects on oxidative stress and glycosylated hemoglobin (HbA1c).</p><p><strong>Methods: </strong>Firstly, the ethyl acetate fraction of <i>Solena heterophylla</i> Lour. fruits was standardized using Cucurbitacin B as a standard marker by conducting HPTLC evaluation. Next, we delved into analyzing metabolite profiling. In addition, the standardized fraction was utilized in an experimental study to investigate the molecular mechanism of action in an <i>in vivo</i> high-fat diet and a low dose of streptozotocin-induced diabetic model.</p><p><strong>Results: </strong>We have reportedly identified 52 metabolites in the ethyl acetate fraction of <i>Solena heterophylla</i> (EASH). In the in vitro tests, it has been observed that this extract from plants possesses notable inhibitory properties against α-amylase and α-glucosidase. <i>Solena heterophylla</i> fruits with high levels of Cucurbitacin B (2.29% w/w) helped lower FBG levels in animals with EASH treatment. EASH treatment reduced HbA1c levels and normalized liver lipid peroxidation and antioxidant enzyme levels. SGOT, SGPT, and SALP serum enzyme levels also returned to normal.</p><p><strong>Conclusion: </strong>Based on the current evaluation, it was found that EASH exhibited encouraging hypoglycemic effects in diabetic rats induced by a low dose of STZ and high-fat diet, which warrants further investigation.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"220-234"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10199775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnomedicinal Importance of Patuletin in Medicine: Pharmacological Activities and Analytical Aspects. Patuletin 的民族药用价值:药理活性和分析方面。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230816141740
Dinesh Kumar Patel, Gireesh Kumar Singh, Gulam Mohammed Husain, Satyendra K Prasad

Background: Plant-derived bioactive molecules have been a major source of therapeutic agents for human and veterinarian purposes. Different traditional medicine system across the globe had relied on natural resources to meet their demand of healthcare. Still in modern world, pharmaceutical industries look for phytochemicals to develop new drugs. The current review explores patuletin, a flavonoid for its diverse reported pharmacological activities along with its analytical techniques.

Methods: Scientific data published on patuletin was collected from Scopus, Science Direct, Pubmed, Google, and Google Scholar. The collected data were analyzed and arranged as per specific pharmacological activities performed using in-vitro or in-vivo methods. Analytical methods of patuletin have been presented next to pharmacological activities Results: Available scientific literature indicates patuletin has anti-inflammatory, cytotoxic, genotoxic, hepatoprotective, antiproliferative, antiplatelet, antinociceptive, and antioxidant activity. In addition to these activities, its biological potential on breast cancer, rheumatoid arthritis, aldose reductase, and different types of microorganisms has been also presented in this work. Analytical data on patuletin signified the importance of patuletin for the standardization of herbal products and derived medicine.

Conclusion: It may be concluded that patuletin with its diverse biological activities and readily available analytical methods, holds the potential to be translated into a new drug entity.

背景:植物提取的生物活性分子一直是人类和兽医治疗药物的主要来源。全球不同的传统医学体系都依赖自然资源来满足其医疗保健需求。在现代社会,制药业仍在寻找植物化学物质来开发新药。本综述探讨了黄酮类化合物帕曲汀的多种药理活性及其分析技术:方法:从 Scopus、Science Direct、Pubmed、Google 和 Google Scholar 上收集有关帕曲汀的科学数据。根据体外或体内方法进行的特定药理活性,对收集到的数据进行了分析和整理。帕曲汀的分析方法紧接着药理活性进行介绍:现有科学文献表明,帕曲汀具有抗炎、细胞毒性、基因毒性、保肝、抗增殖、抗血小板、抗痛觉和抗氧化活性。除了这些活性外,本研究还介绍了它对乳腺癌、类风湿性关节炎、醛糖还原酶和不同类型微生物的生物潜力。有关帕图莱廷的分析数据表明,帕图莱廷对草药产品和衍生药物的标准化具有重要意义:结论:帕妥因具有多种生物活性,而且分析方法简便易行,因此有可能成为一种新的药物实体。
{"title":"Ethnomedicinal Importance of Patuletin in Medicine: Pharmacological Activities and Analytical Aspects.","authors":"Dinesh Kumar Patel, Gireesh Kumar Singh, Gulam Mohammed Husain, Satyendra K Prasad","doi":"10.2174/1871530323666230816141740","DOIUrl":"10.2174/1871530323666230816141740","url":null,"abstract":"<p><strong>Background: </strong>Plant-derived bioactive molecules have been a major source of therapeutic agents for human and veterinarian purposes. Different traditional medicine system across the globe had relied on natural resources to meet their demand of healthcare. Still in modern world, pharmaceutical industries look for phytochemicals to develop new drugs. The current review explores patuletin, a flavonoid for its diverse reported pharmacological activities along with its analytical techniques.</p><p><strong>Methods: </strong>Scientific data published on patuletin was collected from Scopus, Science Direct, Pubmed, Google, and Google Scholar. The collected data were analyzed and arranged as per specific pharmacological activities performed using <i>in-vitro</i> or <i>in-vivo</i> methods. Analytical methods of patuletin have been presented next to pharmacological activities Results: Available scientific literature indicates patuletin has anti-inflammatory, cytotoxic, genotoxic, hepatoprotective, antiproliferative, antiplatelet, antinociceptive, and antioxidant activity. In addition to these activities, its biological potential on breast cancer, rheumatoid arthritis, aldose reductase, and different types of microorganisms has been also presented in this work. Analytical data on patuletin signified the importance of patuletin for the standardization of herbal products and derived medicine.</p><p><strong>Conclusion: </strong>It may be concluded that patuletin with its diverse biological activities and readily available analytical methods, holds the potential to be translated into a new drug entity.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"519-530"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10007300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Disorders Caused by Inborn Errors of Metabolism. 先天性代谢错误引起的肝脏疾病。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230623120935
Omid Vakili, Alireza Mafi, Morteza Pourfarzam

Inborn errors of metabolism (IEMs) are a vast array of inherited/congenital disorders, affecting a wide variety of metabolic pathways and/or biochemical processes inside the cells. Although IEMs are usually rare, they can be represented as serious health problems. During the neonatal period, these inherited defects can give rise to almost all key signs of liver malfunction, including jaundice, coagulopathy, hepato- and splenomegaly, ascites, etc. Since the liver is a vital organ with multiple synthetic, metabolic, and excretory functions, IEM-related hepatic dysfunction could seriously be considered life-threatening. In this context, the identification of those hepatic manifestations and their associated characteristics may promote the differential diagnosis of IEMs immediately after birth, making therapeutic strategies more successful in preventing the occurrence of subsequent events. Among all possible liver defects caused by IEMs, cholestatic jaundice, hepatosplenomegaly, and liver failure have been shown to be manifested more frequently. Therefore, the current study aims to review substantial IEMs that mostly result in the aforementioned hepatic disorders, relying on clinical principles, especially through the first years of life. In this article, a group of uncommon hepatic manifestations linked to IEMs is also discussed in brief.

先天性代谢异常(IEMs)是一系列遗传/先天性疾病,影响细胞内多种代谢途径和/或生化过程。虽然先天性代谢异常通常比较罕见,但它们可能会带来严重的健康问题。在新生儿期,这些遗传性缺陷可引起几乎所有主要的肝功能异常症状,包括黄疸、凝血功能障碍、肝脾肿大、腹水等。由于肝脏是一个重要器官,具有多种合成、代谢和排泄功能,因此与 IEM 相关的肝功能异常严重时会危及生命。因此,识别这些肝脏表现及其相关特征可促进出生后立即对 IEM 进行鉴别诊断,使治疗策略更成功地预防后续事件的发生。在所有可能由 IEMs 引起的肝脏缺陷中,胆汁淤积性黄疸、肝脾肿大和肝功能衰竭已被证明是较常见的表现。因此,本研究旨在根据临床原则,回顾主要导致上述肝脏疾病的大量 IEMs,尤其是在婴儿出生后的最初几年。本文还简要讨论了与 IEM 相关的一组不常见的肝脏表现。
{"title":"Liver Disorders Caused by Inborn Errors of Metabolism.","authors":"Omid Vakili, Alireza Mafi, Morteza Pourfarzam","doi":"10.2174/1871530323666230623120935","DOIUrl":"10.2174/1871530323666230623120935","url":null,"abstract":"<p><p>Inborn errors of metabolism (IEMs) are a vast array of inherited/congenital disorders, affecting a wide variety of metabolic pathways and/or biochemical processes inside the cells. Although IEMs are usually rare, they can be represented as serious health problems. During the neonatal period, these inherited defects can give rise to almost all key signs of liver malfunction, including jaundice, coagulopathy, hepato- and splenomegaly, ascites, etc. Since the liver is a vital organ with multiple synthetic, metabolic, and excretory functions, IEM-related hepatic dysfunction could seriously be considered life-threatening. In this context, the identification of those hepatic manifestations and their associated characteristics may promote the differential diagnosis of IEMs immediately after birth, making therapeutic strategies more successful in preventing the occurrence of subsequent events. Among all possible liver defects caused by IEMs, cholestatic jaundice, hepatosplenomegaly, and liver failure have been shown to be manifested more frequently. Therefore, the current study aims to review substantial IEMs that mostly result in the aforementioned hepatic disorders, relying on clinical principles, especially through the first years of life. In this article, a group of uncommon hepatic manifestations linked to IEMs is also discussed in brief.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"194-207"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10042285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications. 慢性压力是 2 型糖尿病的风险因素:内分泌、代谢和免疫影响。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230803095118
Giuseppe Lisco, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Emilio Jirillo, Elsa Vitale, Vincenzo Triggiani

Background: Chronic stress is a condition of pressure on the brain and whole body, which in the long term may lead to a frank disease status, even including type 2 diabetes (T2D). Stress activates the hypothalamus-pituitary-adrenal axis with release of glucocorticoids (GCs) and catecholamines, as well as activation of the inflammatory pathway of the immune system, which alters glucose and lipid metabolism, ultimately leading to beta-cell destruction, insulin resistance and T2D onset. Alteration of the glucose and lipid metabolism accounts for insulin resistance and T2D outcome. Furthermore, stress-related subversion of the intestinal microbiota leads to an imbalance of the gut-brain-immune axis, as evidenced by the stress-related depression often associated with T2D. A condition of generalized inflammation and subversion of the intestinal microbiota represents another facet of stress-induced disease. In fact, chronic stress acts on the gut-brain axis with multiorgan consequences, as evidenced by the association between depression and T2D. Oxidative stress with the production of reactive oxygen species and cytokine-mediated inflammation represents the main hallmarks of chronic stress. ROS production and pro-inflammatory cytokines represent the main hallmarks of stress-related disorders, and therefore, the use of natural antioxidant and anti-inflammatory substances (nutraceuticals) may offer an alternative therapeutic approach to combat stress-related T2D. Single or combined administration of nutraceuticals would be very beneficial in targeting the neuro-endocrine-immune axis, thus, regulating major pathways involved in T2D onset. However, more clinical trials are needed to establish the effectiveness of nutraceutical treatment, dosage, time of administration and the most favorable combinations of compounds. Therefore, in view of their antioxidant and anti-inflammatory properties, the use of natural products or nutraceuticals for the treatment of stress-related diseases, even including T2D, will be discussed. Several evidences suggest that chronic stress represents one of the main factors responsible for the outcome of T2D.

背景:慢性压力是一种对大脑和全身造成压力的状态,长期可能导致疾病,甚至包括 2 型糖尿病(T2D)。压力会激活下丘脑-垂体-肾上腺轴,释放糖皮质激素(GCs)和儿茶酚胺,并激活免疫系统的炎症途径,从而改变葡萄糖和脂质代谢,最终导致β细胞破坏、胰岛素抵抗和 T2D 发病。葡萄糖和脂质代谢的改变是导致胰岛素抵抗和终末期糖尿病的原因。此外,与压力有关的肠道微生物群破坏会导致肠道-大脑-免疫轴失衡,与 T2D 经常相关的压力相关抑郁症就是证明。普遍的炎症和肠道微生物群的破坏是压力诱发疾病的另一个方面。事实上,慢性压力作用于肠道-大脑轴,会对多个器官造成影响,抑郁症与 T2D 之间的联系就是证明。产生活性氧的氧化应激和细胞因子介导的炎症是慢性压力的主要特征。活性氧的产生和促炎细胞因子是应激相关疾病的主要特征,因此,使用天然抗氧化剂和抗炎物质(营养保健品)可能是对抗与应激相关的 T2D 的另一种治疗方法。单一或联合服用营养保健品将非常有利于针对神经-内分泌-免疫轴,从而调节与 T2D 发病有关的主要途径。然而,还需要更多的临床试验来确定营养保健品的治疗效果、剂量、给药时间和最有利的化合物组合。因此,鉴于天然产品或营养保健品的抗氧化和抗炎特性,我们将讨论如何利用它们来治疗与压力有关的疾病,甚至包括 T2D。一些证据表明,慢性压力是导致 T2D 的主要因素之一。
{"title":"Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications.","authors":"Giuseppe Lisco, Vito Angelo Giagulli, Giovanni De Pergola, Edoardo Guastamacchia, Emilio Jirillo, Elsa Vitale, Vincenzo Triggiani","doi":"10.2174/1871530323666230803095118","DOIUrl":"10.2174/1871530323666230803095118","url":null,"abstract":"<p><strong>Background: </strong>Chronic stress is a condition of pressure on the brain and whole body, which in the long term may lead to a frank disease status, even including type 2 diabetes (T2D). Stress activates the hypothalamus-pituitary-adrenal axis with release of glucocorticoids (GCs) and catecholamines, as well as activation of the inflammatory pathway of the immune system, which alters glucose and lipid metabolism, ultimately leading to beta-cell destruction, insulin resistance and T2D onset. Alteration of the glucose and lipid metabolism accounts for insulin resistance and T2D outcome. Furthermore, stress-related subversion of the intestinal microbiota leads to an imbalance of the gut-brain-immune axis, as evidenced by the stress-related depression often associated with T2D. A condition of generalized inflammation and subversion of the intestinal microbiota represents another facet of stress-induced disease. In fact, chronic stress acts on the gut-brain axis with multiorgan consequences, as evidenced by the association between depression and T2D. Oxidative stress with the production of reactive oxygen species and cytokine-mediated inflammation represents the main hallmarks of chronic stress. ROS production and pro-inflammatory cytokines represent the main hallmarks of stress-related disorders, and therefore, the use of natural antioxidant and anti-inflammatory substances (nutraceuticals) may offer an alternative therapeutic approach to combat stress-related T2D. Single or combined administration of nutraceuticals would be very beneficial in targeting the neuro-endocrine-immune axis, thus, regulating major pathways involved in T2D onset. However, more clinical trials are needed to establish the effectiveness of nutraceutical treatment, dosage, time of administration and the most favorable combinations of compounds. Therefore, in view of their antioxidant and anti-inflammatory properties, the use of natural products or nutraceuticals for the treatment of stress-related diseases, even including T2D, will be discussed. Several evidences suggest that chronic stress represents one of the main factors responsible for the outcome of T2D.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"321-332"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10302435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Live Births in Women over 40 Years of Age Correlate with Obesity Rates. 40 岁以上妇女的活产率与肥胖率相关。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230606120744
Jie Lin, Qian Xie, Chaoran Xu, Qin Wan

Aims: This cross-sectional study aimed to analyze the relationship between live birth and the prevalence of obesity in Chinese women over 40 years of age.

Methods: From April to November 2011, the Endocrinology Branch of the Chinese Medical Association conducted the REACTION project, a national, multicenter, cross-sectional study of Chinese adults aged 40 years and older. Demographic and medical data were collected through validated questionnaires and equipment. Anthropometric indicators, blood pressure, and biochemical data were measured by professional medical personnel. Data were analyzed using descriptive statistics and logistic analysis. Multivariate regression models were used to analyze obesity-related risk factors.

Results: The prevalence of obesity among women increased gradually from 3.8% to 6.0% with an increasing number of live births. Women with two live births had the highest prevalence of overweight at 34.3%. Overall, the obesity and overweight rates were slightly higher in premenopausal women than in postmenopausal women. Univariate regression analysis showed that the risk of obesity in women increased with an increasing number of live births. In addition, multivariate regression analysis showed that the risk of obesity increased with an increasing number of live births in women with systolic blood pressure (SBP) < 121 mmHg or current smoking (P < 0.05).

Conclusion: The risk of obesity increases with the number of live births in Chinese women over 40 years of age with SBP < 121 mmHg or current smoking. Our findings may facilitate the development of interventions to prevent obesity in this population.

目的:本横断面研究旨在分析活产与中国40岁以上女性肥胖患病率之间的关系:2011年4月至11月,中华医学会内分泌学分会开展了REACTION项目,这是一项针对40岁及以上中国成年人的全国性、多中心、横断面研究。通过有效问卷和设备收集了人口统计学和医学数据。人体测量指标、血压和生化数据由专业医务人员测量。数据采用描述性统计和逻辑分析法进行分析。采用多元回归模型分析与肥胖相关的风险因素:随着活产次数的增加,妇女的肥胖率从 3.8%逐渐上升至 6.0%。活产两次的妇女超重率最高,为 34.3%。总体而言,绝经前妇女的肥胖率和超重率略高于绝经后妇女。单变量回归分析表明,妇女肥胖的风险随着活产次数的增加而增加。此外,多变量回归分析表明,在收缩压(SBP)< 121 mmHg 或目前吸烟的妇女中,肥胖风险随着活产次数的增加而增加(P < 0.05):结论:40 岁以上、收缩压小于 121 mmHg 或正在吸烟的中国女性,肥胖风险随着活产次数的增加而增加。我们的研究结果可能有助于制定预防该人群肥胖的干预措施。
{"title":"Live Births in Women over 40 Years of Age Correlate with Obesity Rates.","authors":"Jie Lin, Qian Xie, Chaoran Xu, Qin Wan","doi":"10.2174/1871530323666230606120744","DOIUrl":"10.2174/1871530323666230606120744","url":null,"abstract":"<p><strong>Aims: </strong>This cross-sectional study aimed to analyze the relationship between live birth and the prevalence of obesity in Chinese women over 40 years of age.</p><p><strong>Methods: </strong>From April to November 2011, the Endocrinology Branch of the Chinese Medical Association conducted the REACTION project, a national, multicenter, cross-sectional study of Chinese adults aged 40 years and older. Demographic and medical data were collected through validated questionnaires and equipment. Anthropometric indicators, blood pressure, and biochemical data were measured by professional medical personnel. Data were analyzed using descriptive statistics and logistic analysis. Multivariate regression models were used to analyze obesity-related risk factors.</p><p><strong>Results: </strong>The prevalence of obesity among women increased gradually from 3.8% to 6.0% with an increasing number of live births. Women with two live births had the highest prevalence of overweight at 34.3%. Overall, the obesity and overweight rates were slightly higher in premenopausal women than in postmenopausal women. Univariate regression analysis showed that the risk of obesity in women increased with an increasing number of live births. In addition, multivariate regression analysis showed that the risk of obesity increased with an increasing number of live births in women with systolic blood pressure (SBP) < 121 mmHg or current smoking (P < 0.05).</p><p><strong>Conclusion: </strong>The risk of obesity increases with the number of live births in Chinese women over 40 years of age with SBP < 121 mmHg or current smoking. Our findings may facilitate the development of interventions to prevent obesity in this population.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"255-264"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9584782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypothyroidism in Older Adults: A Narrative Review 老年人甲状腺功能减退症:叙述性综述
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230828110153
Vincenzo Fiore, Alessandra Barucca, S Barraco, Domenico Triggiani, Giovanni Carbotta, Vito Angelo Giagulli, Giuseppina Piazzolla, Giuseppe Lisco, Vincenzo Triggiani

Introduction: The prevalence of hypothyroidism increases along with aging, resulting in one of the most common comorbidities among patients over 75 years. The leading causes of hypothyroidism in older adults are iatrogenic, Hashimoto's thyroiditis, and medications. The narrative review aimed to discuss the clinical characteristics of hypothyroidism in older adults and the impact of hormonal replacement therapy on survival rates. Thyroid function declines over time due to physiological changes in the thyroid stimulating hormone signaling, iodine absorption and metabolism, thyroid hormone metabolism, and activity at peripheral sites. A serum TSH value over the upper limit of the normal reference range is not necessarily attributable to hypothyroidism. However, an appropriate diagnosticwork-up is required to rule out true hypothyroidism and discriminate the etiology (i.e., thyroid autoimmune diseases, iodine deficiency, drug-induced hypothyroidism). Levothyroxine treatment should be considered in cases of overt hypothyroidism. A complete risk-to-benefit assessment, particularly considering the overall health status, life expectancy, cognitive function, mood, and cardiovascular and neurological background, should be considered before treating subclinical hypothyroidism with more potential benefits in patients under 75 years old. Levothyroxine formulations facilitating hormone absorption and increasing compliance to long-term treatment should be preferred. TSH target should usually be set over 3 mIU/ml. Defining optimal diagnostic approaches and targeted therapeutic strategies should be considered in the personalized management of aged patients with hypothyroidism.

简介甲状腺功能减退症的发病率随着年龄的增长而增加,是 75 岁以上患者最常见的合并症之一。导致老年人甲减的主要原因是先天性因素、桥本氏甲状腺炎和药物。叙述性综述旨在讨论老年人甲减的临床特征以及激素替代疗法对生存率的影响。由于促甲状腺激素信号传导、碘的吸收和代谢、甲状腺激素代谢以及外周部位活动的生理变化,甲状腺功能会随着时间的推移而下降。血清促甲状腺激素值超过正常参考范围的上限并不一定是甲状腺功能减退。不过,需要进行适当的诊断检查,以排除真正的甲状腺功能减退症并鉴别病因(即甲状腺自身免疫性疾病、碘缺乏症、药物性甲状腺功能减退症)。对于明显的甲状腺功能减退症,应考虑使用左甲状腺素治疗。在治疗亚临床甲状腺功能减退症之前,应考虑对 75 岁以下患者进行全面的风险与收益评估,特别是要考虑其整体健康状况、预期寿命、认知功能、情绪以及心血管和神经系统背景,因为亚临床甲状腺功能减退症的潜在收益更高。应首选有利于激素吸收和提高长期治疗依从性的左甲状腺素制剂。促甲状腺激素目标值通常应设定在 3 mIU/ml 以上。在对老年甲减患者进行个性化管理时,应考虑确定最佳诊断方法和有针对性的治疗策略。
{"title":"Hypothyroidism in Older Adults: A Narrative Review","authors":"Vincenzo Fiore, Alessandra Barucca, S Barraco, Domenico Triggiani, Giovanni Carbotta, Vito Angelo Giagulli, Giuseppina Piazzolla, Giuseppe Lisco, Vincenzo Triggiani","doi":"10.2174/1871530323666230828110153","DOIUrl":"10.2174/1871530323666230828110153","url":null,"abstract":"<p><strong>Introduction: </strong>The prevalence of hypothyroidism increases along with aging, resulting in one of the most common comorbidities among patients over 75 years. The leading causes of hypothyroidism in older adults are iatrogenic, Hashimoto's thyroiditis, and medications. The narrative review aimed to discuss the clinical characteristics of hypothyroidism in older adults and the impact of hormonal replacement therapy on survival rates. Thyroid function declines over time due to physiological changes in the thyroid stimulating hormone signaling, iodine absorption and metabolism, thyroid hormone metabolism, and activity at peripheral sites. A serum TSH value over the upper limit of the normal reference range is not necessarily attributable to hypothyroidism. However, an appropriate diagnostic\u0000work-up is required to rule out true hypothyroidism and discriminate the etiology (i.e., thyroid autoimmune diseases, iodine deficiency, drug-induced hypothyroidism). Levothyroxine treatment should be considered in cases of overt hypothyroidism. A complete risk-to-benefit assessment, particularly considering the overall health status, life expectancy, cognitive function, mood, and cardiovascular and neurological background, should be considered before treating subclinical hypothyroidism with more potential benefits in patients under 75 years old. Levothyroxine formulations facilitating hormone absorption and increasing compliance to long-term treatment should be preferred. TSH target should usually be set over 3 mIU/ml. Defining optimal diagnostic approaches and targeted therapeutic strategies should be considered in the personalized management of aged patients with hypothyroidism.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"879-884"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10102776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of Mediterranean and Japanese Diets among Nurses: A Scoping Literature Review. 地中海饮食和日本饮食对护士的益处:范围界定文献综述。
IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230825152320
Elsa Vitale

Introduction: The present study aimed at all the benefits induced by taking the Mediterranean or Japanese diet among nurses and whether any beneficial differences in intakes between the two diets were considered.

Methods: The author searched PubMed and Embase databases for medical subheadings terms and free full text referring to "Diet," "Mediterranean," "Japanese," and "Nurses" before 31st December 2022.

Results: A total of 14 studies were included in this scoping review, which better underlined all the benefits implicated in the Mediterranean or Japanese diets assumption and also if there were any differences between the two diets. These eating behaviors were exclusively investigated among nurses.

Conclusion: The nursing profession has always been considered the most stressful healthcare activity. However, some important concerns in the regular lifestyle, such as eating and physical activity, might help to live better.

引言本研究旨在探讨在护士中采用地中海饮食或日本饮食的所有益处,以及是否考虑了两种饮食在摄入量上的益处差异:作者在 2022 年 12 月 31 日之前检索了 PubMed 和 Embase 数据库中有关 "饮食"、"地中海"、"日本 "和 "护士 "的医学副标题和免费全文:本范围综述共纳入了 14 项研究,这些研究更好地强调了地中海或日本饮食假定的所有益处,以及这两种饮食之间是否存在任何差异。这些饮食行为仅在护士中进行了调查:护士职业一直被认为是压力最大的医疗保健活动。然而,常规生活方式中的一些重要问题,如饮食和体育锻炼,可能有助于更好地生活。
{"title":"Benefits of Mediterranean and Japanese Diets among Nurses: A Scoping Literature Review.","authors":"Elsa Vitale","doi":"10.2174/1871530323666230825152320","DOIUrl":"10.2174/1871530323666230825152320","url":null,"abstract":"<p><strong>Introduction: </strong>The present study aimed at all the benefits induced by taking the Mediterranean or Japanese diet among nurses and whether any beneficial differences in intakes between the two diets were considered.</p><p><strong>Methods: </strong>The author searched PubMed and Embase databases for medical subheadings terms and free full text referring to \"Diet,\" \"Mediterranean,\" \"Japanese,\" and \"Nurses\" before 31st December 2022.</p><p><strong>Results: </strong>A total of 14 studies were included in this scoping review, which better underlined all the benefits implicated in the Mediterranean or Japanese diets assumption and also if there were any differences between the two diets. These eating behaviors were exclusively investigated among nurses.</p><p><strong>Conclusion: </strong>The nursing profession has always been considered the most stressful healthcare activity. However, some important concerns in the regular lifestyle, such as eating and physical activity, might help to live better.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"1721-1732"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10111444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Update on Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria. 非甾体类消炎药诱发荨麻疹的最新进展。
IF 1.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-01-01 DOI: 10.2174/1871530323666230907112453
Andrea Miniello, Rossella Casella, Teresa Loverre, Dario Aloia, Danilo Di Bona, Eustachio Nettis

Background: Hypersensitivity reactions to non-steroidal anti-inflammatory drugs (HR-NSAIDs) are common adverse events related to the widespread use of over-the-counter NSAIDs for the treatment of a variety of inflammatory conditions. Urticaria is the most commonly reported immediate cutaneous clinical sign of HR-NSAIDs, but it can be a manifestation of pathophysiologically different clinical entities that require different therapeutic strategies. The aim of this study is to ease the identification of the correct phenotype of HR-NSAIDs in patients reporting urticaria associated with the intake of NSAIDs and provide updated information about their diagnosis and management.

Methods: The study is a narrative review conducted by collecting the most relevant and up-todate data related to the classification, pathophysiology, severity, and prognosis of NSAID hypersensitivity reactions. PubMed and Embase scientific databases were used as search engines to select relevant articles.

Results: Patients developing HR-NSAIDs can be divided into two categories: selective responders (SR), who develop reactions after the administration of a single specific NSAID due to an underlying IgE or T-cell mediated hypersensitivity mechanism, or cross-intolerant (CI), who develop reactions to more than one chemically unrelated NSAIDs due to abnormalities in the biochemical pathways related with prostaglandin metabolism, independently from an underlying immunological mechanism. Five major different categories of HR-NSAIDs have been identified: NSAIDs-exacerbated cutaneous disease (NECD), NSAIDs-induced urticaria/angioedema with/without respiratory and systemic symptoms of anaphylaxis (NIUAA), and NSAIDsexacerbated respiratory disease (NERD), which are developed by CI patients, and single NSAIDs-induced urticaria, angioedema and/ or anaphylaxis (SNIUAA) and single NSAIDsinduced delayed hypersensitivity reactions (SNIDHR), which are developed by CI patients. In vivo and in vitro diagnostic tests have rarely been shown to be reliable in all these entities and therefore are not routinely used in clinical practice. The management in SR patients consists of strict avoidance of the culprit drug, while for cross-intolerance reactions oral tolerance tests with safe alternative drugs (e.g. weak COX-1 inhibitors or selective COX-2 inhibitors) can be performed.

Conclusion: HR-NSAIDs are being observed with increasing frequency, however, the pathogenesis behind some NSAIDS-associated clinical entities is still unclear. Diagnosis is mostly based on a thorough clinical history and confirmed by a drug challenge test. Clinical management is based on strict avoidance and use of alternative tolerated medications. Overall, all therapeutic decisions depend on the correct identification of the type of reaction the patient experienced.

背景:非甾体抗炎药(HR-NSAIDs)过敏反应是广泛使用非处方非甾体抗炎药治疗各种炎症的常见不良反应。荨麻疹是最常报道的HR-NSAIDs直接皮肤临床症状,但它可能是不同临床实体的病理生理表现,需要不同的治疗策略。本研究旨在帮助报告与服用非甾体抗炎药相关的荨麻疹的患者识别正确的 HR-NSAIDs 表型,并提供有关其诊断和管理的最新信息:本研究通过收集与非甾体抗炎药超敏反应的分类、病理生理学、严重程度和预后相关的最新资料,进行了叙述性综述。研究使用PubMed和Embase科学数据库作为搜索引擎,选择相关文章:结果:发生HR-NSAID的患者可分为两类:一类是选择性反应者(SR),即由于潜在的IgE或T细胞介导的超敏反应机制而在服用单一特定NSAID后发生反应;另一类是交叉耐受者(CI),即由于与前列腺素代谢相关的生化途径异常而对多种化学性质无关的NSAID发生反应,与潜在的免疫机制无关。目前已发现五大类不同的 HR-NSAIDs:非甾体抗炎药激惹的皮肤病(NECD)、非甾体抗炎药激惹的荨麻疹/血管性水肿伴/不伴呼吸道和全身过敏性休克症状(NIUAA)和非甾体抗炎药激惹的呼吸道疾病(NERD)、以及单一非甾体抗炎药物诱发的荨麻疹、血管性水肿和/或过敏性休克(SNIUAA)和单一非甾体抗炎药物诱发的迟发性超敏反应(SNIDHR)。体内和体外诊断测试很少被证明对所有这些实体都是可靠的,因此在临床实践中并未常规使用。对 SR 患者的处理包括严格避免使用罪魁祸首药物,而对于交叉耐受反应,可使用安全的替代药物(如弱 COX-1 抑制剂或选择性 COX-2 抑制剂)进行口服耐受试验:结论:HR-NSAIDs 的出现频率越来越高,但一些与 NSAIDS 相关的临床症状的发病机制仍不清楚。诊断主要基于详尽的临床病史,并通过药物挑战试验加以确认。临床管理的基础是严格避免和使用可耐受的替代药物。总之,所有治疗决定都取决于对患者所经历的反应类型的正确识别。
{"title":"An Update on Nonsteroidal Anti-Inflammatory Drug-Induced Urticaria.","authors":"Andrea Miniello, Rossella Casella, Teresa Loverre, Dario Aloia, Danilo Di Bona, Eustachio Nettis","doi":"10.2174/1871530323666230907112453","DOIUrl":"10.2174/1871530323666230907112453","url":null,"abstract":"<p><strong>Background: </strong>Hypersensitivity reactions to non-steroidal anti-inflammatory drugs (HR-NSAIDs) are common adverse events related to the widespread use of over-the-counter NSAIDs for the treatment of a variety of inflammatory conditions. Urticaria is the most commonly reported immediate cutaneous clinical sign of HR-NSAIDs, but it can be a manifestation of pathophysiologically different clinical entities that require different therapeutic strategies. The aim of this study is to ease the identification of the correct phenotype of HR-NSAIDs in patients reporting urticaria associated with the intake of NSAIDs and provide updated information about their diagnosis and management.</p><p><strong>Methods: </strong>The study is a narrative review conducted by collecting the most relevant and up-todate data related to the classification, pathophysiology, severity, and prognosis of NSAID hypersensitivity reactions. PubMed and Embase scientific databases were used as search engines to select relevant articles.</p><p><strong>Results: </strong>Patients developing HR-NSAIDs can be divided into two categories: selective responders (SR), who develop reactions after the administration of a single specific NSAID due to an underlying IgE or T-cell mediated hypersensitivity mechanism, or cross-intolerant (CI), who develop reactions to more than one chemically unrelated NSAIDs due to abnormalities in the biochemical pathways related with prostaglandin metabolism, independently from an underlying immunological mechanism. Five major different categories of HR-NSAIDs have been identified: NSAIDs-exacerbated cutaneous disease (NECD), NSAIDs-induced urticaria/angioedema with/without respiratory and systemic symptoms of anaphylaxis (NIUAA), and NSAIDsexacerbated respiratory disease (NERD), which are developed by CI patients, and single NSAIDs-induced urticaria, angioedema and/ or anaphylaxis (SNIUAA) and single NSAIDsinduced delayed hypersensitivity reactions (SNIDHR), which are developed by CI patients. In vivo and in vitro diagnostic tests have rarely been shown to be reliable in all these entities and therefore are not routinely used in clinical practice. The management in SR patients consists of strict avoidance of the culprit drug, while for cross-intolerance reactions oral tolerance tests with safe alternative drugs (e.g. weak COX-1 inhibitors or selective COX-2 inhibitors) can be performed.</p><p><strong>Conclusion: </strong>HR-NSAIDs are being observed with increasing frequency, however, the pathogenesis behind some NSAIDS-associated clinical entities is still unclear. Diagnosis is mostly based on a thorough clinical history and confirmed by a drug challenge test. Clinical management is based on strict avoidance and use of alternative tolerated medications. Overall, all therapeutic decisions depend on the correct identification of the type of reaction the patient experienced.</p>","PeriodicalId":11614,"journal":{"name":"Endocrine, metabolic & immune disorders drug targets","volume":" ","pages":"885-895"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10199774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrine, metabolic & immune disorders drug targets
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1